Astra CEO Says ‘Several Companies’ Affected by China Problems

AstraZeneca Plc isn’t the only health-care company facing compliance questions in China as concern continued to swirl about a probe into alleged legal breaches tied to drug importation and data privacy.

“Across our own industry, several companies are affected by some of the issues we’re affected by,” Chief Executive Officer Pascal Soriot said Tuesday.

About 100 former Astra employees have been sentenced on charges of medical insurance fraud. A handful of current and former senior executives are under investigation for the alleged illegal importation of cancer drugs. Leon Wang, president of Astra’s China division, is being detained and the company ...